Cleared Traditional

Disposable Blood Lancets (K220387) - FDA 510(k) Clearance

Class II General & Plastic Surgery device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K220387 · Suzhou Kyuan Medical Apparatus Co., Ltd. · General & Plastic Surgery device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2022
Decision
188d
Days
Class 2
Risk

K220387 is an FDA 510(k) clearance for the Disposable Blood Lancets. Classified as Multiple Use Blood Lancet For Single Patient Use Only (product code QRL), Class II - Special Controls.

Submitted by Suzhou Kyuan Medical Apparatus Co., Ltd. (Suzhou, CN). The FDA issued a Cleared decision on August 17, 2022 after a review of 188 days - an extended review cycle.

This device falls under the General & Plastic Surgery FDA review panel, regulated under 21 CFR 878.4850 - the FDA general and plastic surgery device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General & Plastic Surgery review framework, consistent with the majority of Class II 510(k) submissions.

View all Suzhou Kyuan Medical Apparatus Co., Ltd. devices

Submission Details

510(k) Number K220387 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 10, 2022
Decision Date August 17, 2022
Days to Decision 188 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
73d slower than avg
Panel avg: 115d · This submission: 188d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code QRL Multiple Use Blood Lancet For Single Patient Use Only
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 878.4850
Definition A Multiple Use Capable Blood Lancet Intended For Use On A Single Patient That Is Comprised Of A Single Use Blade Attached To A Solid, Reusable Base That Is Used To Puncture The Skin To Obtain A Drop Of Blood For Diagnostic Purposes.
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General & Plastic Surgery devices follow this clearance model.

Regulatory Peers - QRL Multiple Use Blood Lancet For Single Patient Use Only

All 23
Devices cleared under the same product code (QRL) and FDA review panel - the closest regulatory comparables to K220387.
RightLance Blood Lancing System
K222034 · Beijing Ruicheng Medical Supplies Co., Ltd. · Sep 2022
Lancing device
K221970 · SteriLance Medical (Suzhou), Inc. · Aug 2022
OneTouch Delica Plus Lancing System
K221546 · Asahi Polyslider Co., Ltd. · Aug 2022
Lancet (I, II, III, V, VI)
K220475 · Tianjin Huahong Technology Co., Ltd. · Jul 2022
MICROLET NEXT lancing device, MICROLET Lancet
K220633 · Ascensia Diabetes Care U.S., Inc. · Jun 2022
Accu-Chek FastClix Blood Lancing System
K220608 · Roche Diabetes Care, Inc. · Apr 2022